Long-Term Real-World Evaluation of Tofacitinib's Effectiveness and Safety in Japan: Insights Into Optimal Timing for Dose Reduction
{{output}}
Aims: Tofacitinib (TOF), an oral pan-Janus kinase (JAK) inhibitor, is a therapeutic option for moderate to severe ulcerative colitis (UC). While short-term efficacy has been reported, its long-term real-world outcomes-particularl... ...
